We are live on ! Find out more
BIM

Bogle Investment Management Portfolio holdings

AUM $63M
1-Year Est. Return 51.97%
This Fund
S&P 500
This Quarter Est. Return
+16.81%
1 Year Est. Return
+51.97%
3 Year Est. Return
+181.13%
5 Year Est. Return
+959%
10 Year Est. Return
AUM
$818M
AUM Growth
Cap. Flow
+$793M
Cap. Flow %
96.84%
Top 10 Hldgs %
11.1%
Holding
279
New
279
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 16.65%
2 Technology 15.99%
3 Industrials 13.02%
4 Consumer Discretionary 8.44%
5 Financials 6.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLOX
1
DELISTED
Infoblox Inc
BLOX
$10.7M 1.31%
+365,828
New +$8.71M
SNTS
2
DELISTED
SANTARUS INC
SNTS
$10.4M 1.27%
+493,504
New +$9.92M
PPC icon
3
Pilgrim's Pride
PPC
$6.64B
$9.79M 1.2%
+655,513
New +$7.32M
SWFT
4
DELISTED
Swift Transportation Company
SWFT
$9.49M 1.16%
+574,105
New +$8.81M
KKD
5
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
$9.37M 1.14%
+536,972
New +$8.01M
HIMX
6
Himax Technologies
HIMX
$2.31B
$8.48M 1.04%
+1,624,400
New +$9.98M
BBBY
7
Bed Bath & Beyond
BBBY
$471M
$8.3M 1.01%
+391,757
New +$6.56M
SBS icon
8
Sabesp
SBS
$20.1B
$8.22M 1%
+4,073,673
New +$10.6M
MBI icon
9
MBIA
MBI
$293M
$8.1M 0.99%
+608,580
New +$7.64M
CRL icon
10
Charles River Laboratories
CRL
$11B
$8M 0.98%
+194,935
New +$8.35M
BRCD
11
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
$7.99M 0.98%
+1,387,428
New +$7.75M
IONS icon
12
Ionis Pharmaceuticals
IONS
$9.23B
$7.92M 0.97%
+294,607
New +$6.26M
VNDA icon
13
Vanda Pharmaceuticals
VNDA
$322M
$7.85M 0.96%
+971,983
New +$6.55M
UTHR icon
14
United Therapeutics
UTHR
$26.4B
$7.83M 0.96%
+118,943
New +$7.66M
DAL icon
15
Delta Air Lines
DAL
$53.9B
$7.78M 0.95%
+415,686
New +$7.21M
AZPN
16
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$7.77M 0.95%
+269,900
New +$7.77M
ICLR icon
17
Icon
ICLR
$13.1B
$7.65M 0.93%
+215,878
New +$7.1M
OWW
18
DELISTED
ORBITZ WORLDWIDE, INC
OWW
$7.64M 0.93%
+951,734
New +$6.79M
MX icon
19
Magnachip Semiconductor
MX
$133M
$7.63M 0.93%
+417,861
New +$7.02M
MYGN icon
20
Myriad Genetics
MYGN
$538M
$7.52M 0.92%
+279,758
New +$8.11M
EVC icon
21
Entravision Communication
EVC
$969M
$7.46M 0.91%
+1,213,891
New +$5.4M
CLGX
22
DELISTED
Corelogic, Inc.
CLGX
$7.16M 0.87%
+308,980
New +$7.87M
HSH
23
DELISTED
HILLSHIRE BRANDS CO
HSH
$7.09M 0.87%
+214,288
New +$7.41M
WX
24
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
$6.88M 0.84%
+327,678
New +$6.4M
MANH icon
25
Manhattan Associates
MANH
$8.72B
$6.77M 0.83%
+350,764
New +$6.42M

Similar funds

Bogle Investment Management's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Bogle Investment Management, which disclosed 279 positions worth $818M. Its ten largest holdings account for 11% of the portfolio.

Its largest position is NATIONAL BANK OF GREECE SA ADR REPSTG 1 SHARE (NEW): 1,361,967 shares worth $4.7M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, followed by Technology and Industrials.

  • Bogle Investment Management's largest Q2 2013 buy was NATIONAL BANK OF GREECE SA ADR REPSTG 1 SHARE (NEW): 1,361,967 shares worth $4.7M.
  • Bogle Investment Management's ten largest holdings make up 11% of its $818M portfolio in Q2 2013.
  • Bogle Investment Management disclosed 279 positions in Q2 2013, its first 13F filing on record.

Based on Bogle Investment Management's 13F filing for Q2 2013, filed 14 Aug 2013.